# ERTAPENEM SODIUM
> **ANDA218067** · Abbreviated New Drug Application (Generic) · Sponsor: QILU ANTIBIOTICS · Approved 2024-10-31
## Drug
- **FDA Application Number:** ANDA218067
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERTAPENEM SODIUM
- **Generic name:** ERTAPENEM SODIUM
- **Active ingredients:** ERTAPENEM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** QILU ANTIBIOTICS
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2024-10-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218067)
---
*MORVS · CC0 1.0*